Literature DB >> 1679298

Conjunctival impression cytology in patients with glaucoma using long-term topical medication.

J D Brandt1, J R Wittpenn, L J Katz, W N Steinmann, G L Spaeth.   

Abstract

Increasing evidence indicates that long-term use of topically administered medications can induce changes in the conjunctiva and ocular surface. We used the technique of conjunctival impression cytology to evaluate the conjunctival changes that develop with long-term use of topically administered antiglaucoma medications. Patients with glaucoma who were on a stable regimen of one, two, or three topically administered medications were recruited for study; glaucoma suspects who were not using topically administered medications served as controls. Eyes with clinical or historical evidence of external eye disease or conjunctival surgery were excluded. Impression cytology specimens, collected from the bulbar and palpebral conjunctiva, were coded and subsequently graded by a masked observer. We examined specimens from 72 eyes by using this technique. Aggregate scores for the bulbar conjunctiva were compiled, using a previously described grading system with a range of 0 (normal) to 3 (diffuse, severe metaplasia). The results show statistically significant degrees of conjunctival metaplasia associated with the number of glaucoma medications used. These results suggest that the long-term use of antiglaucoma medications induces changes in the conjunctival surface. These changes may be related to the medications themselves, the preservatives in the commercial preparations, or the duration of topical treatment. The clinical relevance of these changes remains unknown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679298     DOI: 10.1016/s0002-9394(14)76730-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  27 in total

1.  Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal (Brit. Engl) response.

Authors:  R Nuzzi; C Finazzo; A Cerruti
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Effects of long-term topical anti-glaucoma medications on meibomian glands.

Authors:  Reiko Arita; Kouzo Itoh; Shuji Maeda; Koshi Maeda; Ayumu Furuta; Atsuo Tomidokoro; Makoto Aihara; Shiro Amano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-18       Impact factor: 3.117

3.  Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.

Authors:  R L Gross
Journal:  Trans Am Ophthalmol Soc       Date:  1999

4.  Associated morbidity of nasolacrimal duct obstruction--a large community based case-control study.

Authors:  Arie Y Nemet; Shlomo Vinker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-22       Impact factor: 3.117

5.  CA 19-9 ELISA test: a new method for studying mucus changes in tears.

Authors:  C Garcher; A Bron; C Baudouin; L Bildstein; J Bara
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

6.  Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.

Authors:  C Baudouin; C de Lunardo
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

7.  Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.

Authors:  P J Pisella; P Pouliquen; C Baudouin
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

8.  The effects of long-term topical glaucoma medication on conjunctival impression cytology.

Authors:  E Turaçli; K Budak; A Kaur; B Mizrak; C Ekinci
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

9.  Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study.

Authors:  R Nuzzi; A Vercelli; C Finazzo; C Cracco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-03       Impact factor: 3.117

Review 10.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.